Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: A phase II study of methotrexate, cisplatin and bleomycin

Keyphrases

• Cisplatin 100%
• Methotrexate 100%
• Squamous Cell Carcinoma (SqCC) 100%
• Combination Chemotherapy 100%
• Locally Advanced 100%
• Bleomycin 100%
• Phase I Study 100%
• Median Survival 50%
• Objective Response 50%
• Disease-free Status 50%
• Thrombocytopenia 25%
• Toxic Effects 25%
• Complete Response 25%
• Partial Response 25%
• Multidisciplinary Approach 25%
• Radiation Therapy 25%
• Overall Response Rate 25%
• Active Agent 25%
• Complete Response Rate 25%
• Response Rate 25%
• Neutropenia 25%
• Hematotoxicity 25%
• Renal Toxicity 25%
• Stomatitis 25%
• Duration of Response 25%
• Duration Data 25%
• Disease-free 25%
• Advanced Squamous Cell Carcinoma 25%
• Neutropenic Sepsis 25%
• Surgery Therapy 25%
• Single-agent Chemotherapy 25%
• 95% Confidence Interval 25%
• Non-haematological 25%

Nursing and Health Professions

• Methotrexate 100%
• Cisplatin 100%
• Combination Chemotherapy 100%
• Bleomycin 100%
• Squamous Cell Carcinoma 100%
• Diseases 60%
• Confidence Interval 20%
• Thrombocytopenia 20%
• Sepsis 20%
• Nephrotoxicity 20%
• Neutropenia 20%
• Radiotherapy 20%
• Chemotherapy 20%
• Efficacy 20%
• Stomatitis 20%